Awaiting development: Guidance and quality standards

Showing 241 to 250 of 391

Guidance and quality standards awaiting development
Title	Type
Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions	HealthTech guidance
Percutaneous transluminal renal sympathetic denervation for resistant hypertension	HealthTech guidance
Pernicious anaemia	Quality standard
Pirtobrutinib for treating relapsed or refractory mantle cell lymphoma untreated with a BTK inhibitor [ID6493]	Technology appraisal guidance
Pirtobrutinib with venetoclax and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6566]	Technology appraisal guidance
Plinabulin with docetaxel for previously treated advanced non-small-cell lung cancer [ID3895]	Technology appraisal guidance
PLX-PAD for treating muscle injury after arthroplasty for hip fracture in people 60 to 90 years [ID3989]	Technology appraisal guidance
Point-of-care lipid tests for cardiovascular disease prevention in primary and community care	HealthTech guidance
Port Delivery Platform with ranibizumab for treating wet age-related macular degeneration [ID3983]	Technology appraisal guidance
Povorcitinib for treating non-segmental vitiligo [TSID12388]	Technology appraisal guidance